Learning Objectives:
1. Understand definition N2 disease in NSCLC
2. Summarize complete phase III trials leading to current treatement strategies
3. Discuss next steps for management of N2 disease
Session date:
09/28/2020 - 12:00pm to 1:00pm CDT
Location:
Virtually
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Jori B. Sheade, MD